You browser is out of date and some functionality on this site may be not supported.
Please consider upgrading to the latest version of your browser for the best possible experience.
Kindly note that this website is not compatible with this browser. Some features may not work. Inconvenience regretted.
Early detection and screening of SCID-SMA is a vital health goal for infants
The NeoNat SCID SMA is a Real-Time PCR assay for screening Severe Combined Immunodeficiency (SCID) Syndrome and Spinal Muscular Atrophy (SMA) in newborns DNA from Dried Blood Spot (DBS) samples.